rs267608300

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000106.6(CYP2D6):​c.667-150G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00451 in 1,013,822 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.0041 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 112 hom. )

Consequence

CYP2D6
NM_000106.6 intron

Scores

2

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: -3.33

Publications

3 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS2
High AC in GnomAd4 at 612 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2D6NM_000106.6 linkc.667-150G>A intron_variant Intron 4 of 8 ENST00000645361.2 NP_000097.3 P10635-1C1ID52Q5Y7H2
CYP2D6NM_001025161.3 linkc.514-150G>A intron_variant Intron 3 of 7 NP_001020332.2 P10635-2Q5Y7H2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2D6ENST00000645361.2 linkc.667-150G>A intron_variant Intron 4 of 8 NM_000106.6 ENSP00000496150.1 P10635-1

Frequencies

GnomAD3 genomes
AF:
0.00406
AC:
611
AN:
150652
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000986
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00303
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00520
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00650
Gnomad OTH
AF:
0.00630
GnomAD4 exome
AF:
0.00458
AC:
3956
AN:
863058
Hom.:
112
AF XY:
0.00449
AC XY:
1997
AN XY:
444678
show subpopulations
African (AFR)
AF:
0.000847
AC:
18
AN:
21256
American (AMR)
AF:
0.00256
AC:
89
AN:
34802
Ashkenazi Jewish (ASJ)
AF:
0.00200
AC:
43
AN:
21482
East Asian (EAS)
AF:
0.0000282
AC:
1
AN:
35400
South Asian (SAS)
AF:
0.000424
AC:
29
AN:
68448
European-Finnish (FIN)
AF:
0.00695
AC:
340
AN:
48954
Middle Eastern (MID)
AF:
0.000245
AC:
1
AN:
4080
European-Non Finnish (NFE)
AF:
0.00557
AC:
3275
AN:
588066
Other (OTH)
AF:
0.00394
AC:
160
AN:
40570
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
195
389
584
778
973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00406
AC:
612
AN:
150764
Hom.:
19
Cov.:
32
AF XY:
0.00382
AC XY:
281
AN XY:
73626
show subpopulations
African (AFR)
AF:
0.000983
AC:
40
AN:
40702
American (AMR)
AF:
0.00310
AC:
47
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4758
European-Finnish (FIN)
AF:
0.00520
AC:
55
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00650
AC:
440
AN:
67660
Other (OTH)
AF:
0.00624
AC:
13
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00672
Hom.:
5
Bravo
AF:
0.00354

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.0050
DANN
Benign
0.61
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608300; hg19: chr22-42524502; API